We have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations. Our team of over 100 distinguished scientific, medical, investment, and other professionals manages over $18 billion across public and private company investments worldwide.

Life Sciences Focus

The global healthcare industry sits at the intersection of several powerful long-term growth trends led by global demographics and the ineluctable advance of scientific innovation in treating disease.

These trends have caused a steady increase in the level of healthcare spending in the industrialized world, led by the U.S. which now spends over 17% of its GDP on healthcare. The healthcare industry's powerful growth profile coupled with its magnitude and complexity create myriad investment opportunities.

Our Strategies

OrbiMed invests across the global healthcare industry, from seed-stage venture capital to large publicly-traded companies. Investments are made in one of three strategies: public equity, private equity, and private credit/royalty.

Public Equity
OrbiMed manages a series of public equity funds, including long/short event-driven funds and closed-end investment trusts. We invest across all types of publicly-traded companies, from biopharmaceuticals to medical devices and healthcare services worldwide.
Private Equity
OrbiMed's private equity strategy is broad and flexible, investing from start-ups through growth equity. OrbiMed is typically a lead investor, helping to build our portfolio companies into market leaders. We invest globally, including across North America, Asia, and Europe.
Private Credit/Royalty
OrbiMed provides commercial-stage healthcare companies with non-dilutive structured debt capital. Additionally, OrbiMed can monetize royalty streams, providing valuable financing solutions to owners of intellectual property.

Firm History

To thrive, organisms need to adapt and grow. So do investment firms. Through 25 years of volatile, changing investment environments, we've embraced new opportunities and expanded our global footprint.

 
1989
OrbiMed's investment business was founded in New York City
 
1993
Launched our first long/short fund and made our first venture capital investment
 
2000
Launched our first dedicated venture capital fund
 
2007
Opened offices in San Francisco and Shanghai, China
 
2008
Opened office in Mumbai, India
 
2010
Opened office in Herzliya, Israel
 
2011
Launched our first dedicated royalty / credit fund
 
2015
Hired our 100th employee
2017
Opened office in Hong Kong
Our team has helped nurture and commercialize some of today's most successful healthcare companies.